Alopecia After Cosmetic Injection Procedures: A Review.

Naiem T Issa, Michael Kaiser, Abril Martinez-Velasco, Antonella Tosti
Author Information
  1. Naiem T Issa: Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida.
  2. Michael Kaiser: Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida.
  3. Abril Martinez-Velasco: Clinica de Oncodermatología, Universidad Nacional Autonoma de México, Ciudad de México, Cuauhtémoc, Mexico.
  4. Antonella Tosti: Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida.

Abstract

BACKGROUND: Cosmetic procedures for antiaging carry inherent risks of adverse events. One that has not yet been well characterized is transitory or permanent alopecia. This is attributable to numerous mechanisms including pressure, ischemia, inflammation, and necrosis. Cases of postcosmetic procedure alopecia have been reported after mesotherapy as well as hyaluronic acid filler, deoxycholic acid, and botulinum toxin injections.
OBJECTIVE: This review serves to describe the currently known causes of postcosmetic procedure alopecia and the mechanisms by which alopecia is attained. Furthermore, this review highlights the risk of unregulated mesotherapy injections for cosmetic enhancement and to bring attention to the increasing number reports of alopecia after these procedures.
METHODS: A systematic review of the literature from 2000 to 2022 was conducted looking for keywords such as "alopecia," "cosmetic procedures," "mesotherapy," and "hyaluronic acid" in Google Scholar and PubMed.
RESULTS: Ten articles met the criteria set forth in the authors' literature review. Many of the procedures resulted in partial or complete resolution of alopecia.
CONCLUSION: Alopecia after cosmetic injection procedures is an underreported adverse effect. More research is needed to further characterize the risk of alopecia after mesotherapy and other injection procedures.

References

  1. Mysore V. Mesotherapy in management of hairloss—is it of any use? Int J Trichol 2010;2:45.
  2. Atiyeh BS, Abou Ghanem O. An update on facial skin rejuvenation effectiveness of mesotherapy EBM V. J Craniofac Surg 2021;32:2168–71.
  3. Duque-Estrada B, Vincenzi C, Misciali C, Tosti A. Alopecia secondary to mesotherapy. J Am Acad Dermatol 2009;61:707–9.
  4. Melo DF, de Mattos Barreto T, Plata GT, Araujo LR, et al. Excellent response to mesotherapy as adjunctive treatment in male androgenetic alopecia. J Cosmet Dermatol 2020;19:75–7.
  5. Herz-Ruelas ME, Álvarez-Villalobos NA, Millán-Alanís JM, de León-Gutiérrez H, et al. Efficacy of intralesional and oral dutasteride in the treatment of androgenetic alopecia: a systematic review. Skin Appendage Disord 2020;6:1–8.
  6. Saceda-Corralo D, Rodrigues-Barata AR, Vano-Galvan S, Jaen-Olasolo P. Mesotherapy with dutasteride in the treatment of androgenetic alopecia. Int J Trichol 2017;9:143.
  7. Moftah N, Moftah N, Abd‐Elaziz G, Ahmed N, et al. Mesotherapy using dutasteride‐containing preparation in treatment of female pattern hair loss: photographic, morphometric and ultrustructural evaluation. J Eur Acad Dermatol Venereol 2013;27:686–93.
  8. Abdallah MAER, Shareef R, Soltan MY. Efficacy of intradermal minoxidil 5% injections for treatment of patchy non-severe alopecia areata. J Dermatol Treat 2020;33:1126–1129.
  9. Azam MH, Morsi HM. Comparative study between 2% minoxidil topical spray vs. intradermal injection (Mesotherapy) for treatment of androgenetic alopecia in female patients: a controlled, 4-month randomized trial. Egypt Dermatol Online J 2010;6:5.
  10. Magdaleno-Tapial J, Valenzuela-Oñate C, García-Legaz-Martínez M, Martínez-Domenech Á, et al. Angioedema-like contact dermatitis caused by mesotherapy with dutasteride. Contact Dermatitis 2020;83:246–7.
  11. Apsner R, Hörl WH, Sunder-Plassmann G. Dalteparin-induced alopecia in hemodialysis patients: reversal by regional citrate anticoagulation. Blood. J Am Soc Hematol 2001;97:2914–5.
  12. Barnes C, Deidun D, Hynes K, Monagle P. Alopecia and dalteparin: a previously unreported association. Blood. J Am Soc Hematol 2000;96:1618–9.
  13. EL‐Komy M, Hassan A, Tawdy A, Solimon M, et al. Hair loss at injection sites of mesotherapy for alopecia. J Cosmet Dermatol 2017;16:e28–e30.
  14. Kadry R, Hamadah I, Al-Issa A, Field L, et al. Multifocal scalp abscess with subcutaneous fat necrosis and scarring alopecia as a complication of scalp mesotherapy. J Drugs Dermatol JDD 2008;7:72–3.
  15. Prevention. Outbreak of mesotherapy-associated skin reactions-District of Columbia area, January-February 2005. MMWR Morbidity Mortality Weekly Rep 2005;54:1127–30.
  16. Grady B, Porphirio F, Rokhsar C. Submental alopecia at deoxycholic acid injection site. Dermatol Surg 2017;43:1105–8.
  17. Georgesen C, Lipner SR. The development, evidence, and current use of ATX‐101 for the treatment of submental fat. J Cosmet Dermatol 2017;16:174–9.
  18. Kybella P. Kybella (Deoxycholic Acid) Injection Prescribing Information. Westlake Village, CA. Kythera BiopharmaceuticalsInc; 2015.
  19. Shridharani SM, Chandawarkar AA. Alopecia in male patients treated with ATX-101 (deoxycholic acid) for submental fullness. Plast Reconstr Surg Glob Open 2017;5:194–195.
  20. Sebaratnam DF, Wong XL, Kim L, Cheung K. Alopecia following deoxycholic acid treatment for submental adiposity. JAMA Facial Plast Surg 2019;21:571–2.
  21. Park MJ, Hong SP, Kim MH, Park BC. Temporary hair loss with an increase of telogen hairs after filler migration into the scalp. Dermatol Surg 2020;46:1129–31.
  22. Gan SD, Itkin A, Wolpowitz D. Hyaluronic acid-induced alopecia: a novel complication. Dermatol Surg 2013;39:1724–5.
  23. Hanly AJ, Jorda M, Badiavas E, Valencia I, et al. Postoperative pressure-induced alopecia: report of a case and discussion of the role of apoptosis in non-scarring alopecia. J Cutan Pathol 1999;26:357–61.
  24. Suwanchinda A, Webb KL, Rudolph C, Hladik C, et al. The posterior temporal supraSMAS minimally invasive lifting technique using soft‐tissue fillers. J Cosmet Dermatol 2018;17:617–24.
  25. Di Pietro A, Piraccini BM. Frontal alopecia after repeated botulinum toxin type A injections for forehead wrinkles: an underestimated entity? Skin Appendage Disord 2016;2:67–9.
  26. Kowing D. Madarosis and facial alopecia presumed secondary to botulinum a toxin injections. Optom Vis Sci 2005;82:579–82.
  27. Pearce C. Information on a possible association between botulinum toxin treatment and alopecia. 2016.
  28. Carloni R, Pechevy L, Postel F, Zielinski M, et al. Is there a therapeutic effect of botulinum toxin on scalp alopecia? Physiopathology and reported cases: a systematic review of the literature. J Plast Reconstr Aesthet Surg 2020;73:2210–6.
  29. Singh S, Neema S, Vasudevan B. A pilot study to evaluate effectiveness of botulinum toxin in treatment of androgenetic alopecia in males. J Cutan Aesthet Surg 2017;10:163.
  30. Nassar A, Abdel-Aleem H, Samir M, Khattab FM. Efficacy of botulinum toxin A injection in the treatment of androgenic alopecia: a Comparative Controlled Study. J Cosmet Dermatol 2022:1–8.
  31. Khunkhet S, Rattananukrom T, Thanasarnaksorn W, Suchonwanit P. Alopecia induced by autologous fat injection into the temporal area: case report and review of the literature. Case Rep Dermatol 2019;11:150–6.
  32. Souyoul S, Gioe O, Emerson A, Hooper DOB. Alopecia after injection of ATX-101 for reduction of submental fat. JAAD case Rep 2017;3:250.
  33. Park GH, Kim WI, Yang MY, Lee WK, et al. Filler-induced alopecia. J Dermatol 2019;46:e392–e393.
  34. Asz-Sigall D, Iñigo-Gomez K, Ortega-Springall MF, Vega-Memije ME, et al. Alopecia secondary to hyaluronic acid embolization: trichoscopic findings. Skin appendage Disord 2019;5:396–400.

MeSH Term

Alopecia
Cosmetic Techniques
Humans
Hyaluronic Acid
Mesotherapy

Chemicals

Hyaluronic Acid

Word Cloud

Created with Highcharts 10.0.0alopeciaproceduresreviewmesotherapy"CosmeticadversewellmechanismspostcosmeticprocedureacidinjectionsriskcosmeticliteratureAlopeciainjectionBACKGROUND:antiagingcarryinherentriskseventsOneyetcharacterizedtransitorypermanentattributablenumerousincludingpressureischemiainflammationnecrosisCasesreportedhyaluronicfillerdeoxycholicbotulinumtoxinOBJECTIVE:servesdescribecurrentlyknowncausesattainedFurthermorehighlightsunregulatedenhancementbringattentionincreasingnumberreportsMETHODS:systematic20002022conductedlookingkeywords"alopecia"cosmetic"mesotherapy"hyaluronicacid"GoogleScholarPubMedRESULTS:Tenarticlesmetcriteriasetforthauthors'ManyresultedpartialcompleteresolutionCONCLUSION:underreportedeffectresearchneededcharacterizeInjectionProcedures:Review

Similar Articles

Cited By